openPR Logo
Press release

Neuroprotection Market to Reach US$ 60.1 Billion by 2031, Driven by Rising Prevalence of Neurological Disorders and Advancements in Drug Development

03-11-2025 03:41 AM CET | Health & Medicine

Press release from: Transparency Market Research

Neuroprotection Market

Neuroprotection Market

The global neuroprotection market was valued at US$ 31.6 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2031, reaching an estimated value of US$ 60.1 billion by the end of 2031. The increasing prevalence of neurodegenerative disorders, rising investment in pharmaceutical research, and advancements in neuroprotective therapies are key drivers of market growth.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40553

Market Dynamics

Drivers:

Rising Prevalence of Neurodegenerative Diseases: Increasing cases of Alzheimer's, Parkinson's, and multiple sclerosis are driving demand for neuroprotective drugs.

Advancements in Drug Development: New research in regenerative medicine, stem cell therapy, and novel drug formulations are enhancing neuroprotection treatment outcomes.

Government and Private Funding for Neurological Research: Increased investments in neuroscience and neuroprotection therapies are accelerating innovation.

Aging Population: The growing elderly population, more susceptible to neurodegenerative diseases, is fueling market expansion.

Restraints:

High Costs of Neuroprotective Drugs: Expensive drug development and treatment costs may limit accessibility, especially in developing regions.

Stringent Regulatory Approvals: Complex approval processes for new drugs can delay market entry.

Limited Awareness in Low-income Countries: Lack of awareness and access to neuroprotection therapies in certain regions may hinder market growth.

Opportunities:

Emerging Biomarker-Based Therapies: Increased research in biomarkers for early detection and treatment of neurological disorders presents new opportunities.

Growth in Personalized Medicine: Advancements in genetics and precision medicine are paving the way for individualized neuroprotection therapies.

Increased Collaboration Between Biotech and Pharma Companies: Strategic partnerships are accelerating drug discovery and commercialization.

Competitive Landscape The neuroprotection market is highly competitive, with key players focusing on new drug approvals, mergers, acquisitions, and technological innovations.

Leading companies include:

Daiichi Sankyo Company
Eli Lilly and Company
AbbVie Inc.
Dr. Reddy's Laboratories Ltd.
Teva Pharmaceutical Industries Ltd.
Novartis AG
AstraZeneca plc.
Astrocyte Pharmaceuticals, Inc.
F. Hoffmann-La Roche AG
Biogen Inc.

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40553

Market Segmentation

By Drug Class:

NMDA Receptor Antagonists

Free Radical Trappers

Anti-inflammatory Agents

Mitochondrial Dysfunction Regulators

Others

By Indication:

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

Stroke

Others

By End-User:

Hospitals

Specialty Clinics

Research Institutes

Regional Outlook

North America: The largest market due to advanced healthcare infrastructure, strong R&D investments, and high prevalence of neurodegenerative disorders.

Europe: Government-backed neurological research programs and increasing elderly population contribute to market growth.

Asia-Pacific: Expected to witness the highest growth due to increasing healthcare investments, rising disease awareness, and expanding pharmaceutical industry.

Latin America & Middle East & Africa: Steady growth driven by improving healthcare facilities and increasing government support for neurological research.

Explore Latest Research Reports by Transparency Market Research:

Dental Gypsum Market- https://www.globenewswire.com/news-release/2024/03/14/2846441/32656/en/Dental-Gypsum-Market-Projected-to-Reach-USD-180-1-million-by-2031-Growing-at-a-CAGR-of-5-1-Transparency-Market-Research-Inc.html

Aerospace Composites Market- https://www.globenewswire.com/news-release/2024/02/27/2835814/32656/en/Aerospace-Composites-Market-Size-is-Anticipated-to-Reach-USD-40-5-billion-Rising-at-a-CAGR-of-9-7-by-2031-Transparency-Market-Research-Inc.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuroprotection Market to Reach US$ 60.1 Billion by 2031, Driven by Rising Prevalence of Neurological Disorders and Advancements in Drug Development here

News-ID: 3908147 • Views:

More Releases from Transparency Market Research

Home Sequential Compression Devices Market Forecast 2031: Increasing VTE Prevention and Post-surgical Rehabilitation Fueling Adoption | Transparency Market Research, Inc
Home Sequential Compression Devices Market Forecast 2031: Increasing VTE Prevent …
Home Sequential Compression Devices (SCDs) are engineered for home use to promote blood circulation and mitigate the risk of blood clots, especially in individuals susceptible to deep vein thrombosis (DVT) and other venous disorders. These devices, typically featuring inflatable sleeves or cuffs that cyclically inflate and deflate, play a critical role in enhancing vascular health, particularly for patients recovering from surgery or those with limited mobility. Valued at US$ 1.1
Asia Pacific Medical Tourism Market Forecast 2031: Affordable Treatment and World-Class Healthcare Facilities Driving Growth | Transparency Market Research, Inc
Asia Pacific Medical Tourism Market Forecast 2031: Affordable Treatment and Worl …
Medical tourism in Asia Pacific has witnessed remarkable growth over the past decade, establishing the region as a premier destination for international patients seeking world-class healthcare services. Valued at US$ 4.3 Bn in 2022, the market is driven by a blend of affordable, high-quality medical care and cutting-edge technology, making the region an attractive alternative to Western healthcare systems. Governments across Asia have actively promoted medical tourism through supportive policies
Infusion Pumps Market Forecast 2031: Rising Chronic Disease Burden and Hospital Infrastructure Boost Demand | Transparency Market Research, Inc
Infusion Pumps Market Forecast 2031: Rising Chronic Disease Burden and Hospital …
Patients managing chronic illnesses and conditions require continuous, precise treatment and care. This has propelled the need for advanced technologies that can accurately monitor, administer, and track medications, ensuring that patients receive the exact dosage required-neither an underdose nor an overdose. Infusion pumps serve as a critical component in this care continuum by enabling controlled and accurate delivery of medical fluids. Valued at US$ 10.3 Bn in 2022, the global
India Cleanroom Gloves Market Forecast 2031: Growing Pharma Manufacturing and Regulatory Compliance Fuel Market Growth | Transparency Market Research,
India Cleanroom Gloves Market Forecast 2031: Growing Pharma Manufacturing and Re …
The India cleanroom gloves market is on a steady growth trajectory, with an anticipated compound annual growth rate (CAGR) of 5.7% from 2023 to 2031. Valued at US$ 22.1 million in 2022, the market is expected to exceed US$ 35.9 million by the end of 2031. This growth is driven by stringent hygiene standards, rising safety protocols across industries, and increasing investments in cleanroom facilities. Preview crucial insights and findings from

All 5 Releases


More Releases for Neuroprotection

Global Neuroprotection Market Status and Future Forecast 2013-2023
Key Content of Chapters (Including and can be customized) Part 1: Market Overview, Development, and Segment by Type, Application & Region Part 2: Global Market by company, Type, Application & Region Part 3: Asia Market by company, Type, Application & Region Download exclusive Sample of this report: @ https://www.researchgoal.com/reports/99SHeaAS09390 Part 4-10: Key Regions of Asia Market by Type, Application Part 11: Company information, Sales, Cost, Margin etc. Part 12: Conclusion Market Segment as follows: By Region Global (Asia, Europe, America etc.) Asia (China, Southeast Asia, India, Japan,
Global Neuroprotection Market Research
The Global Neuroprotection Market Research Global Neuroprotection Market Research neuroprotection showcase was esteemed at roughly US$ 47,000.0 Mn in 2016 is anticipated to enroll a development rate of 8.2% from 2017 to 2025, as per another report distributed by Transparency Market Research (TMR) titled "Neuroprotection Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017– 2025". The Global Neuroprotection Market Research report proposes that expanding occurrence and predominance
Neuroprotection Market Size, Regional Outlook, Competitive Strategies and Foreca …
'International Neuroprotection Market, 2019-2025 Research Report' gives a special instrument to assessing the market, featured openings, and supporting key and strategic basic leadership. This Neuroprotection report perceives that in this quickly advancing and aggressive condition, up-coming promoting data is fundamental to screen execution and settle on basic choices for Neuroprotection development and productivity. It gives data on patterns and advancements, and spotlights on global Neuroprotection market business sectors and materials,
Neuroprotection Market to Expand with Significant CAGR by 2025
The global Neuroprotection Market was valued at approximately US$ 47,000.0 Mn in 2016 is projected to register a growth rate of 8.2% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Neuroprotection Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that increasing incidence and prevalence rates of neurological disorders such as Alzheimer’s, Parkinson’s, Macular Sclerosis ,and
Global Neuroprotection Market 2018 - Teva Pharmaceutical, Novartis, AstraZeneca
Eminent Market, recently published a detailed market research study focused on the Neuroprotection Market across the global, regional and country level. The report provides 360° analysis of Neuroprotection Market from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Neuroprotection industry, and estimates the future trend of Neuroprotection market on the basis of this
Neuroprotection Market CAGR Projected to Grow at 8.2% through 2025
The global neuroprotection market was valued at approximately US$ 47,000.0 Mn in 2016 is projected to register a growth rate of 8.2% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Neuroprotection Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that increasing incidence and prevalence rates of neurological disorders such as Alzheimer’s, Parkinson’s, Macular